{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T05:49:25Z","timestamp":1787636965299,"version":"build-2736575974"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-026-05840-w","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:17:53Z","timestamp":1774916273000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cocaine Use Disorder: Neuropathology and Exploratory Treatments"],"prefix":"10.1007","volume":"63","author":[{"given":"Amanda","family":"Almeida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1643-2011","authenticated-orcid":false,"suffix":"IV","given":"Halford G.","family":"Warlick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arisha","family":"Arain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simran","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erick","family":"Boldt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Causicaa","family":"Chandramohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prathmica","family":"Chandramohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maiah","family":"Fogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Gogerdchian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Borna","family":"Hajivandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armena","family":"Jafarmadar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Koleng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Paparozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge Rubinos","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Santaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeline","family":"Sardinas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafay","family":"Wahid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talha","family":"Wahid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelley","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,31]]},"reference":[{"key":"5840_CR1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425787","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2022","unstructured":"American Psychiatric Association (2022) Diagnostic and statistical manual of mental disorders. American Psychiatric Association publishing. https:\/\/doi.org\/10.1176\/appi.books.9780890425787"},{"key":"5840_CR2","doi-asserted-by":"publisher","first-page":"3576","DOI":"10.1007\/s12035-018-1325-0","volume":"56","author":"S Sil","year":"2019","unstructured":"Sil S, Niu F, Tom E, Liao K, Periyasamy P, Buch S (2019) Cocaine mediated neuroinflammation: role of dysregulated autophagy in pericytes. Mol Neurobiol 56:3576\u20133590. https:\/\/doi.org\/10.1007\/s12035-018-1325-0","journal-title":"Mol Neurobiol"},{"key":"5840_CR3","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1039\/a707613d","volume":"17","author":"D O\u2019Hagan","year":"2000","unstructured":"O\u2019Hagan D (2000) Pyrrole, pyrrolidine, pyridine, piperidine and tropane alkaloids. Nat Prod Rep 17:435\u2013446. https:\/\/doi.org\/10.1039\/a707613d","journal-title":"Nat Prod Rep"},{"key":"5840_CR4","unstructured":"Drugs.com. Scopolamine monograph for professionals. https:\/\/www.drugs.com\/monograph\/scopolamine.html. Accessed January 17, 2026"},{"key":"5840_CR5","unstructured":"PubChem Compound Summary for CID 446220, Cocaine (2025) National Center for Biotechnology Information PubChem. https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Cocaine. Accessed January 17, 2026"},{"key":"5840_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/toxins14040278","volume":"14","author":"R Roque Bravo","year":"2022","unstructured":"Roque Bravo R, Faria AC, Brito-da-Costa AM, Carmo H, Mlad\u011bnka P, Dias Da Silva D, Remi\u00e3o F (2022) Cocaine: an updated overview on chemistry, detection, biokinetics, and pharmacotoxicological aspects including abuse pattern. Toxins (Basel) 14:278. https:\/\/doi.org\/10.3390\/toxins14040278","journal-title":"Toxins (Basel)"},{"key":"5840_CR7","doi-asserted-by":"publisher","first-page":"10759","DOI":"10.1523\/JNEUROSCI.1703-16.2016","volume":"36","author":"M Creed","year":"2016","unstructured":"Creed M, Kaufling J, Fois GR, Jalabert M, Yuan T, L\u00fcscher C, Georges F, Bellone C (2016) Cocaine exposure enhances the activity of ventral tegmental area dopamine neurons via calcium-impermeable NMDARs. J Neurosci 36:10759\u201310768. https:\/\/doi.org\/10.1523\/JNEUROSCI.1703-16.2016","journal-title":"J Neurosci"},{"key":"5840_CR8","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1038\/s41380-024-02443-6","volume":"29","author":"H Li","year":"2024","unstructured":"Li H, Watkins LR, Wang X (2024) Microglia in neuroimmunopharmacology and drug addiction. Mol Psychiatry 29:1912\u20131924. https:\/\/doi.org\/10.1038\/s41380-024-02443-6","journal-title":"Mol Psychiatry"},{"key":"5840_CR9","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41380-021-01112-2","volume":"27","author":"AK Zinsmaier","year":"2022","unstructured":"Zinsmaier AK, Dong Y, Huang YH (2022) Cocaine-induced projection-specific and cell type-specific adaptations in the nucleus accumbens. Mol Psychiatry 27:669\u2013686. https:\/\/doi.org\/10.1038\/s41380-021-01112-2","journal-title":"Mol Psychiatry"},{"key":"5840_CR10","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.conb.2018.08.013","volume":"54","author":"TC Francis","year":"2019","unstructured":"Francis TC, Gantz SC, Moussawi K, Bonci A (2019) Synaptic and intrinsic plasticity in the ventral tegmental area after chronic cocaine. Curr Opin Neurobiol 54:66\u201372. https:\/\/doi.org\/10.1016\/j.conb.2018.08.013","journal-title":"Curr Opin Neurobiol"},{"key":"5840_CR11","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.neuropharm.2017.04.005","volume":"119","author":"KT Schmidt","year":"2017","unstructured":"Schmidt KT, Schroeder JP, Foster SL, Squires K, Smith BM, Pitts EG, Epstein MP, Weinshenker D (2017) Norepinephrine regulates cocaine-primed reinstatement via \u03b11-adrenergic receptors in the medial prefrontal cortex. Neuropharmacology 119:134\u2013140. https:\/\/doi.org\/10.1016\/j.neuropharm.2017.04.005","journal-title":"Neuropharmacology"},{"key":"5840_CR12","unstructured":"Bamalan OA, Moore MJ, Al Khalili Y (2023) Physiology, Serotonin. In: StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL). Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK545168\/"},{"key":"5840_CR13","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1126\/science.abi9086","volume":"373","author":"Y Li","year":"2021","unstructured":"Li Y, Simmler LD, Van Zessen R, Flakowski J, Wan JX, Deng F, Li YL, Nautiyal KM, et al. (2021) Synaptic mechanism underlying serotonin modulation of transition to cocaine addiction. Science 373:1252\u20131256. https:\/\/doi.org\/10.1126\/science.abi9086","journal-title":"Science"},{"key":"5840_CR14","doi-asserted-by":"publisher","first-page":"3421","DOI":"10.1016\/j.neuron.2021.08.012","volume":"109","author":"S Gong","year":"2021","unstructured":"Gong S, Fayette N, Heinsbroek JA, Ford CP (2021) Cocaine shifts dopamine D2 receptor sensitivity to gate conditioned behaviors. Neuron 109:3421-3435.e5. https:\/\/doi.org\/10.1016\/j.neuron.2021.08.012","journal-title":"Neuron"},{"key":"5840_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fncir.2013.00152","volume":"7","author":"JH Baik","year":"2013","unstructured":"Baik JH (2013) Dopamine signaling in reward-related behaviors. Front Neural Circuits 7:152. https:\/\/doi.org\/10.3389\/fncir.2013.00152","journal-title":"Front Neural Circuits"},{"key":"5840_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2022.979078","volume":"16","author":"H Chen","year":"2022","unstructured":"Chen H, Chen L, Yuan Z, Yuan J, Li Y, Xu Y, Wu J, Zhang L, et al. (2022) Glutamate receptor-interacting protein 1 in D1- and D2-dopamine receptor-expressing medium spiny neurons differentially regulates cocaine acquisition, reinstatement, and associated spine plasticity. Front Cell Neurosci 16:979078. https:\/\/doi.org\/10.3389\/fncel.2022.979078","journal-title":"Front Cell Neurosci"},{"key":"5840_CR17","doi-asserted-by":"publisher","first-page":"7781","DOI":"10.1523\/JNEUROSCI.21-19-07781.2001","volume":"21","author":"LR McMahon","year":"2001","unstructured":"McMahon LR, Filip M, Cunningham KA (2001) Differential regulation of the mesoaccumbens circuit by serotonin 5-Hydroxytryptamine (5-HT)2A and 5-HT2C receptors. J Neurosci 21:7781\u20137787. https:\/\/doi.org\/10.1523\/JNEUROSCI.21-19-07781.2001","journal-title":"J Neurosci"},{"key":"5840_CR18","doi-asserted-by":"publisher","first-page":"5300","DOI":"10.1073\/pnas.091039298","volume":"98","author":"I Sora","year":"2001","unstructured":"Sora I, Hall FS, Andrews AM, Itokawa M, Li XF, Wei HB, Wichems C, Lesch KP, et al. (2001) Molecular mechanisms of cocaine reward: combined dopamine and serotonin transporter knockouts eliminate cocaine place preference. Proc Natl Acad Sci USA 98:5300\u20135305. https:\/\/doi.org\/10.1073\/pnas.091039298","journal-title":"Proc Natl Acad Sci USA"},{"key":"5840_CR19","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.neuroscience.2009.05.058","volume":"162","author":"FS Hall","year":"2009","unstructured":"Hall FS, Li XF, Randall-Thompson J, Sora I, Murphy DL, Lesch KP, Caron M, Uhl GR (2009) Cocaine-conditioned locomotion in dopamine transporter, norepinephrine transporter and 5-HT transporter knockout mice. Neuroscience 162:870\u2013880. https:\/\/doi.org\/10.1016\/j.neuroscience.2009.05.058","journal-title":"Neuroscience"},{"key":"5840_CR20","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1523\/JNEUROSCI.4037-08.2009","volume":"29","author":"M Thomsen","year":"2009","unstructured":"Thomsen M, Hall FS, Uhl GR, Caine SB (2009) Dramatically decreased cocaine self-administration in dopamine but not serotonin transporter knock-out mice. J Neurosci 29:1087\u20131092. https:\/\/doi.org\/10.1523\/JNEUROSCI.4037-08.2009","journal-title":"J Neurosci"},{"key":"5840_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2014.00204","volume":"5","author":"JL Cadet","year":"2014","unstructured":"Cadet JL, Bisagno V (2014) Glial-neuronal ensembles: partners in drug addiction-associated synaptic plasticity. Front Pharmacol 5:204. https:\/\/doi.org\/10.3389\/fphar.2014.00204","journal-title":"Front Pharmacol"},{"key":"5840_CR22","doi-asserted-by":"publisher","first-page":"584","DOI":"10.3390\/ijms20030584","volume":"20","author":"ST Kim","year":"2019","unstructured":"Kim ST, Park T (2019) Acute and chronic effects of cocaine on cardiovascular health. Int J Mol Sci 20:584. https:\/\/doi.org\/10.3390\/ijms20030584","journal-title":"Int J Mol Sci"},{"key":"5840_CR23","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.7326\/0003-4819-135-11-200112040-00026","volume":"135","author":"DS Goldstein","year":"2001","unstructured":"Goldstein DS, Li ST, Kopin IJ (2001) Sympathetic neurocirculatory failure in Parkinson disease: evidence for an etiologic role of \u03b1-synuclein. Ann Intern Med 135:1010\u20131011. https:\/\/doi.org\/10.7326\/0003-4819-135-11-200112040-00026","journal-title":"Ann Intern Med"},{"key":"5840_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbih.2019.100030","volume":"2","author":"RA Nolan","year":"2020","unstructured":"Nolan RA, Reeb KL, Rong Y, Matt SM, Johnson HS, Runner K, Gaskill PJ (2020) Dopamine activates NF-\u03baB and primes the NLRP3 inflammasome in primary human macrophages. Brain Behav Immun Health 2:100030. https:\/\/doi.org\/10.1016\/j.bbih.2019.100030","journal-title":"Brain Behav Immun Health"},{"key":"5840_CR25","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1038\/sj.npp.1301663","volume":"33","author":"AJ Ramsey","year":"2008","unstructured":"Ramsey AJ, Laakso A, Cyr M, Sotnikova TD, Salahpour A, Medvedev IO, Dykstra LA, Gainetdinov RR, et al. (2008) Genetic NMDA receptor deficiency disrupts acute and chronic effects of cocaine but not amphetamine. Neuropsychopharmacology 33:2701\u20132714. https:\/\/doi.org\/10.1038\/sj.npp.1301663","journal-title":"Neuropsychopharmacology"},{"key":"5840_CR26","doi-asserted-by":"publisher","first-page":"7482","DOI":"10.1523\/JNEUROSCI.1312-04.2004","volume":"24","author":"SL Borgland","year":"2004","unstructured":"Borgland SL, Malenka RC, Bonci A (2004) Acute and chronic cocaine-induced potentiation of synaptic strength in the ventral tegmental area: electrophysiological and behavioral correlates in individual rats. J Neurosci 24:7482\u20137490. https:\/\/doi.org\/10.1523\/JNEUROSCI.1312-04.2004","journal-title":"J Neurosci"},{"key":"5840_CR27","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.2174\/1570159X17666190617101726","volume":"17","author":"I Smaga","year":"2019","unstructured":"Smaga I, Sanak M, Filip M (2019) Cocaine-induced changes in the expression of NMDA receptor subunits. Curr Neuropharmacol 17:1039\u20131055. https:\/\/doi.org\/10.2174\/1570159X17666190617101726","journal-title":"Curr Neuropharmacol"},{"key":"5840_CR28","doi-asserted-by":"publisher","first-page":"474","DOI":"10.3109\/1547691X.2015.1130760","volume":"13","author":"S Sil","year":"2016","unstructured":"Sil S, Ghosh T, Ghosh R (2016) NMDA receptor is involved in neuroinflammation in intracerebroventricular colchicine-injected rats. J Immunotoxicol 13:474\u2013489. https:\/\/doi.org\/10.3109\/1547691X.2015.1130760","journal-title":"J Immunotoxicol"},{"key":"5840_CR29","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1006\/clim.1998.4683","volume":"91","author":"X Gan","year":"1999","unstructured":"Gan X, Zhang L, Berger O, Stins MF, Way D, Taub DD, Chang SL, Kim KS, et al. (1999) Cocaine enhances brain endothelial adhesion molecules and leukocyte migration. Clin Immunol 91:68\u201376. https:\/\/doi.org\/10.1006\/clim.1998.4683","journal-title":"Clin Immunol"},{"key":"5840_CR30","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s11481-007-9091-1","volume":"3","author":"NK Dhillon","year":"2008","unstructured":"Dhillon NK, Peng F, Bokhari S, Callen S, Shin SH, Zhu X, Kim KJ, Buch SJ (2008) Cocaine-mediated alteration in tight junction protein expression and modulation of CCL2\/CCR2 axis across the blood-brain barrier: implications for HIV-dementia. J Neuroimmune Pharmacol 3:52\u201356. https:\/\/doi.org\/10.1007\/s11481-007-9091-1","journal-title":"J Neuroimmune Pharmacol"},{"key":"5840_CR31","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.1182\/blood-2010-10-313593","volume":"117","author":"H Yao","year":"2011","unstructured":"Yao H, Duan M, Buch S (2011) Cocaine-mediated induction of platelet-derived growth factor: implication for increased vascular permeability. Blood 117:2538\u20132547. https:\/\/doi.org\/10.1182\/blood-2010-10-313593","journal-title":"Blood"},{"key":"5840_CR32","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nm1787","volume":"14","author":"EJ Su","year":"2008","unstructured":"Su EJ, Fredriksson L, Geyer M, Folestad E, Cale J, Andrae J, Gao Y, Pietras K, et al. (2008) Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke. Nat Med 14:731\u2013737. https:\/\/doi.org\/10.1038\/nm1787","journal-title":"Nat Med"},{"key":"5840_CR33","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1074\/jbc.R116.760215","volume":"292","author":"HL McConnell","year":"2017","unstructured":"McConnell HL, Kersch CN, Woltjer RL, Neuwelt EA (2017) The translational significance of the neurovascular unit. J Biol Chem 292:762\u2013770. https:\/\/doi.org\/10.1074\/jbc.R116.760215","journal-title":"J Biol Chem"},{"key":"5840_CR34","doi-asserted-by":"publisher","first-page":"9144","DOI":"10.3390\/ijms24119144","volume":"24","author":"GS Gullotta","year":"2023","unstructured":"Gullotta GS, Costantino G, Sortino MA, Spampinato SF (2023) Microglia and the blood-brain barrier: an external player in acute and chronic neuroinflammatory conditions. Int J Mol Sci 24:9144. https:\/\/doi.org\/10.3390\/ijms24119144","journal-title":"Int J Mol Sci"},{"key":"5840_CR35","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1080\/15548627.2015.1052205","volume":"11","author":"ML Guo","year":"2015","unstructured":"Guo ML, Liao K, Periyasamy P, Yang L, Cai Y, Callen SE, Buch S (2015) Cocaine-mediated microglial activation involves the ER stress-autophagy axis. Autophagy 11:995\u20131009. https:\/\/doi.org\/10.1080\/15548627.2015.1052205","journal-title":"Autophagy"},{"key":"5840_CR36","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1080\/15548627.2016.1183844","volume":"12","author":"P Periyasamy","year":"2016","unstructured":"Periyasamy P, Guo ML, Buch S (2016) Cocaine induces astrocytosis through ER stress-mediated activation of autophagy. Autophagy 12:1310\u20131329. https:\/\/doi.org\/10.1080\/15548627.2016.1183844","journal-title":"Autophagy"},{"key":"5840_CR37","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.pbb.2019.01.007","volume":"179","author":"M Kohno","year":"2019","unstructured":"Kohno M, Link J, Dennis LE, McCready H, Huckans M, Hoffman WF, Loftis JM (2019) Neuroinflammation in addiction: a review of neuroimaging studies and potential immunotherapies. Pharmacol Biochem Behav 179:34\u201342. https:\/\/doi.org\/10.1016\/j.pbb.2019.01.007","journal-title":"Pharmacol Biochem Behav"},{"key":"5840_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00231","volume":"10","author":"M Meijerink","year":"2019","unstructured":"Meijerink M, van den Broek T, Dulos R, Neergaard Jacobsen L, Staudt Kvistgaard A, Garthoff J, Knippels L, Knipping K, et al. (2019) The impact of immune interventions: a systems biology strategy for predicting adverse and beneficial immune effects. Front Immunol 10:231. https:\/\/doi.org\/10.3389\/fimmu.2019.00231","journal-title":"Front Immunol"},{"key":"5840_CR39","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.neuropharm.2013.05.039","volume":"76","author":"MR Hutchinson","year":"2014","unstructured":"Hutchinson MR, Watkins LR (2014) Why is neuroimmunopharmacology crucial for the future of addiction research? Neuropharmacology 76:218\u2013227. https:\/\/doi.org\/10.1016\/j.neuropharm.2013.05.039","journal-title":"Neuropharmacology"},{"key":"5840_CR40","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1182\/blood-2008-12-191296","volume":"114","author":"MA Brockman","year":"2009","unstructured":"Brockman MA, Kwon DS, Tighe DP, Pavlik DF, Rosato PC, Sela J, Porichis F, Le Gall S, et al. (2009) IL-10 is up-regulated in multiple cell types during viremic HIV infection and reversibly inhibits virus-specific T cells. Blood 114:346\u2013356. https:\/\/doi.org\/10.1182\/blood-2008-12-191296","journal-title":"Blood"},{"key":"5840_CR41","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.yfrne.2012.08.006","volume":"33","author":"SD Bilbo","year":"2012","unstructured":"Bilbo SD, Schwarz JM (2012) The immune system and developmental programming of brain and behavior. Front Neuroendocrinol 33:267\u2013286. https:\/\/doi.org\/10.1016\/j.yfrne.2012.08.006","journal-title":"Front Neuroendocrinol"},{"key":"5840_CR42","doi-asserted-by":"publisher","unstructured":"Gabay C (2006) Interleukin-6 and chronic inflammation. Arthritis Res Ther 8(Suppl 2)(Suppl 2)(Suppl 2)):S3. https:\/\/doi.org\/10.1186\/ar1917","DOI":"10.1186\/ar1917"},{"key":"5840_CR43","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/0166-2236(91)90141-g","volume":"14","author":"MJ Kuhar","year":"1991","unstructured":"Kuhar MJ, Ritz MC, Boja JW (1991) The dopamine hypothesis of the reinforcing properties of cocaine. Trends Neurosci 14:299\u2013302. https:\/\/doi.org\/10.1016\/0166-2236(91)90141-g","journal-title":"Trends Neurosci"},{"key":"5840_CR44","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/nrn1406","volume":"5","author":"RA Wise","year":"2004","unstructured":"Wise RA (2004) Dopamine, learning and motivation. Nat Rev Neurosci 5:483\u2013494. https:\/\/doi.org\/10.1038\/nrn1406","journal-title":"Nat Rev Neurosci"},{"key":"5840_CR45","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.biopsych.2010.06.026","volume":"69","author":"MJ Ferris","year":"2011","unstructured":"Ferris MJ, Mateo Y, Roberts DC, Jones SR (2011) Cocaine-insensitive dopamine transporters with intact substrate transport produced by self-administration. Biol Psychiatry 69:201\u2013207. https:\/\/doi.org\/10.1016\/j.biopsych.2010.06.026","journal-title":"Biol Psychiatry"},{"key":"5840_CR46","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1111\/j.1471-4159.2007.05195.x","volume":"105","author":"N Chen","year":"2008","unstructured":"Chen N, Reith ME (2008) Substrates dissociate dopamine transporter oligomers. J Neurochem 105:910\u2013920. https:\/\/doi.org\/10.1111\/j.1471-4159.2007.05195.x","journal-title":"J Neurochem"},{"key":"5840_CR47","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1523\/JNEUROSCI.2604-17.2017","volume":"38","author":"CA Siciliano","year":"2018","unstructured":"Siciliano CA, Saha K, Calipari ES, Fordahl SC, Chen R, Khoshbouei H, Jones SR (2018) Amphetamine reverses escalated cocaine intake via restoration of dopamine transporter conformation. J Neurosci 38:484\u2013497. https:\/\/doi.org\/10.1523\/JNEUROSCI.2604-17.2017","journal-title":"J Neurosci"},{"key":"5840_CR48","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/s0306-4522(02)00379-2","volume":"115","author":"FS Hall","year":"2002","unstructured":"Hall FS, Li XF, Sora I, Xu F, Caron M, Lesch KP, Murphy DL, Uhl GR (2002) Cocaine mechanisms: enhanced cocaine, fluoxetine and nisoxetine place preferences following monoamine transporter deletions. Neuroscience 115:153\u2013161. https:\/\/doi.org\/10.1016\/s0306-4522(02)00379-2","journal-title":"Neuroscience"},{"key":"5840_CR49","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1073\/pnas.0207805101","volume":"101","author":"Y Mateo","year":"2004","unstructured":"Mateo Y, Budygin EA, John CE, Jones SR (2004) Role of serotonin in cocaine effects in mice with reduced dopamine transporter function. Proc Natl Acad Sci U S A 101:372\u2013377. https:\/\/doi.org\/10.1073\/pnas.0207805101","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5840_CR50","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1038\/npp.2013.136","volume":"38","author":"ES Calipari","year":"2013","unstructured":"Calipari ES, Ferris MJ, Zimmer BA, Roberts DC, Jones SR (2013) Temporal pattern of cocaine intake determines tolerance vs sensitization of cocaine effects at the dopamine transporter. Neuropsychopharmacology 38:2385\u20132392. https:\/\/doi.org\/10.1038\/npp.2013.136","journal-title":"Neuropsychopharmacology"},{"key":"5840_CR51","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/jnc.13025","volume":"133","author":"J Zhen","year":"2015","unstructured":"Zhen J, Antonio T, Cheng SY, Ali S, Jones KT, Reith ME (2015) Dopamine transporter oligomerization: impact of combining protomers with differential cocaine analog binding affinities. J Neurochem 133:167\u2013173. https:\/\/doi.org\/10.1111\/jnc.13025","journal-title":"J Neurochem"},{"key":"5840_CR52","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aax1532","volume":"5","author":"KM Kampman","year":"2019","unstructured":"Kampman KM (2019) The treatment of cocaine use disorder. Sci Adv 5:eaax1532. https:\/\/doi.org\/10.1126\/sciadv.aax1532","journal-title":"Sci Adv"},{"key":"5840_CR53","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.8049","volume":"4","author":"BS Bentzley","year":"2021","unstructured":"Bentzley BS, Han SS, Neuner S, Humphreys K, Kampman KM, Halpern CH (2021) Comparison of treatments for cocaine use disorder among adults: a systematic review and meta-analysis. JAMA Netw Open 4:e218049. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.8049","journal-title":"JAMA Netw Open"},{"key":"5840_CR54","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1111\/add.15242","volume":"116","author":"L Brandt","year":"2021","unstructured":"Brandt L, Chao T, Comer SD, Levin FR (2021) Pharmacotherapeutic strategies for treating cocaine use disorder-what do we have to offer? Addiction 116:694\u2013710. https:\/\/doi.org\/10.1111\/add.15242","journal-title":"Addiction"},{"key":"5840_CR55","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.22498","volume":"14","author":"J Pergolizzi","year":"2022","unstructured":"Pergolizzi J, Breve F, Magnusson P, LeQuang JA, Varrassi G (2022) Cocaethylene: when cocaine and alcohol are taken together. Cureus 14:e22498. https:\/\/doi.org\/10.7759\/cureus.22498","journal-title":"Cureus"},{"key":"5840_CR56","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13051475","volume":"13","author":"J van Amsterdam","year":"2024","unstructured":"van Amsterdam J, Gresnigt F, van den Brink W (2024) Cardiovascular risks of simultaneous use of alcohol and cocaine-a systematic review. J Clin Med 13:1475. https:\/\/doi.org\/10.3390\/jcm13051475","journal-title":"J Clin Med"},{"key":"5840_CR57","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1016\/j.vaccine.2023.02.031","volume":"41","author":"B Sabato","year":"2023","unstructured":"Sabato B, Augusto PS, Lima Gon\u00e7alves Pereira R, Coutinho Batista Esteves F, Caligiorne SM, Rodrigues Dias Assis B, Apolo Correia Marcelino S, Pires do Esp\u00edrito Santo L, et al. (2023) Safety and immunogenicity of the anti-cocaine vaccine UFMG-VAC-V4N2 in a non-human primate model. Vaccine 41:2127\u20132136. https:\/\/doi.org\/10.1016\/j.vaccine.2023.02.031","journal-title":"Vaccine"},{"key":"5840_CR58","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.drugalcdep.2007.11.004","volume":"94","author":"JM Schmitz","year":"2008","unstructured":"Schmitz JM, Mooney ME, Moeller FG, Stotts AL, Green C, Grabowski J (2008) Levodopa pharmacotherapy for cocaine dependence: choosing the optimal behavioral therapy platform. Drug Alcohol Depend 94:142\u2013150. https:\/\/doi.org\/10.1016\/j.drugalcdep.2007.11.004","journal-title":"Drug Alcohol Depend"},{"key":"5840_CR59","unstructured":"Stokes M, Patel P, Abdijadid S (2024) Disulfiram. In: StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL). Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK459340\/"},{"key":"5840_CR60","doi-asserted-by":"publisher","first-page":"524","DOI":"10.3390\/antibiotics12030524","volume":"12","author":"J Lanz","year":"2023","unstructured":"Lanz J, Biniaz-Harris N, Kuvaldina M, Jain S, Lewis K, Fallon BA (2023) Disulfiram: mechanisms, applications, and challenges. Antibiotics (Basel) 12:524. https:\/\/doi.org\/10.3390\/antibiotics12030524","journal-title":"Antibiotics (Basel)"},{"key":"5840_CR61","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.drugalcdep.2015.12.036","volume":"160","author":"KM Carroll","year":"2016","unstructured":"Carroll KM, Nich C, Petry NM, Eagan DA, Shi JM, Ball SA (2016) A randomized factorial trial of disulfiram and contingency management to enhance cognitive behavioral therapy for cocaine dependence. Drug Alcohol Depend 160:135\u2013142. https:\/\/doi.org\/10.1016\/j.drugalcdep.2015.12.036","journal-title":"Drug Alcohol Depend"},{"key":"5840_CR62","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007024.pub3","author":"F Traccis","year":"2024","unstructured":"Traccis F, Minozzi S, Trogu E, Vacca R, Vecchi S, Pani PP, Agabio R (2024) Disulfiram for the treatment of cocaine dependence. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD007024.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"5840_CR63","doi-asserted-by":"publisher","first-page":"315","DOI":"10.2174\/1570159x14666160324144912","volume":"15","author":"C Roncero","year":"2017","unstructured":"Roncero C, Abad AC, Padilla-Mata A, Ros-Cucurull E, Barral C, Casas M, Grau-L\u00f3pez L (2017) Psychotic symptoms associated with the use of dopaminergic drugs, in patients with cocaine dependence or abuse. Curr Neuropharmacol 15:315\u2013323. https:\/\/doi.org\/10.2174\/1570159x14666160324144912","journal-title":"Curr Neuropharmacol"},{"key":"5840_CR64","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/acem.14584","volume":"30","author":"S Shastry","year":"2023","unstructured":"Shastry S, Manoochehri O, Richardson LD, Manini AF (2023) Cocaethylene cardiotoxicity in emergency department patients with acute drug overdose. Acad Emerg Med 30:82\u201388. https:\/\/doi.org\/10.1111\/acem.14584","journal-title":"Acad Emerg Med"},{"key":"5840_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2022.109273","volume":"232","author":"JA Tamargo","year":"2022","unstructured":"Tamargo JA, Sherman KE, S\u00e9kaly RP, Bordi R, Schlatzer D, Lai S, Khalsa JH, Mandler RN, et al. (2022) Cocaethylene, simultaneous alcohol and cocaine use, and liver fibrosis in people living with and without HIV. Drug Alcohol Depend 232:109273. https:\/\/doi.org\/10.1016\/j.drugalcdep.2022.109273","journal-title":"Drug Alcohol Depend"},{"key":"5840_CR66","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1093\/alcalc\/agad009","volume":"58","author":"A Helander","year":"2023","unstructured":"Helander A, Vill\u00e9n T, Signell P (2023) Urine drug tests indicate higher prevalence of combined alcohol and cocaine use compared to alcohol together with cannabis or amphetamine-a possible link to cocaethylene. Alcohol Alcohol 58:274\u2013279. https:\/\/doi.org\/10.1093\/alcalc\/agad009","journal-title":"Alcohol Alcohol"},{"key":"5840_CR67","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1124\/mi.9.4.6","volume":"9","author":"M Gaval-Cruz","year":"2009","unstructured":"Gaval-Cruz M, Weinshenker D (2009) Mechanisms of disulfiram-induced cocaine abstinence: antabuse and cocaine relapse. Mol Interv 9:175\u2013187. https:\/\/doi.org\/10.1124\/mi.9.4.6","journal-title":"Mol Interv"},{"key":"5840_CR68","unstructured":"FDA (2024) Wellbutrin. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2024\/018644s061lbl.pdf#page=32. Accessed January 17, 2026"},{"key":"5840_CR69","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1300\/J069v27n01_02","volume":"27","author":"S Shoptaw","year":"2008","unstructured":"Shoptaw S, Heinzerling KG, Rotheram-Fuller E, Kao UH, Wang PC, Bholat MA, Ling W (2008) Bupropion hydrochloride versus placebo, in combination with cognitive behavioral therapy, for the treatment of cocaine abuse\/dependence. J Addict Dis 27:13\u201323. https:\/\/doi.org\/10.1300\/J069v27n01_02","journal-title":"J Addict Dis"},{"key":"5840_CR70","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1001\/archpsyc.63.2.219","volume":"63","author":"J Poling","year":"2006","unstructured":"Poling J, Oliveto A, Petry N, Sofuoglu M, Gonsai K, Gonzalez G, Martell B, Kosten TR (2006) Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population. Arch Gen Psychiatry 63:219\u2013228. https:\/\/doi.org\/10.1001\/archpsyc.63.2.219","journal-title":"Arch Gen Psychiatry"},{"key":"5840_CR71","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/0376-8716(95)01198-6","volume":"40","author":"A Margolin","year":"1995","unstructured":"Margolin A, Kosten TR, Avants SK, Wilkins J, Ling W, Beckson M, Arndt IO, Cornish J, et al. (1995) A multicenter trial of bupropion for cocaine dependence in methadone-maintained patients. Drug Alcohol Depend 40:125\u2013131. https:\/\/doi.org\/10.1016\/0376-8716(95)01198-6","journal-title":"Drug Alcohol Depend"},{"key":"5840_CR72","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1177\/02698811241312680","volume":"39","author":"TJ Templeton-Jager","year":"2025","unstructured":"Templeton-Jager TJ, Diarra S, Kelley LK, Gilpin NW (2025) Systemic bupropion treatment reduces long-access cocaine self-administration in male and female rats. J Psychopharmacol 39:282\u2013294. https:\/\/doi.org\/10.1177\/02698811241312680","journal-title":"J Psychopharmacol"},{"key":"5840_CR73","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph21081105","volume":"21","author":"MG Carbone","year":"2024","unstructured":"Carbone MG, Maremmani I (2024) Chronic cocaine use and Parkinson\u2019s disease: an interpretative model. Int J Environ Res Public Health 21:1105. https:\/\/doi.org\/10.3390\/ijerph21081105","journal-title":"Int J Environ Res Public Health"},{"key":"5840_CR74","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1016\/s0264-410x(01)00425-x","volume":"20","author":"TR Kosten","year":"2002","unstructured":"Kosten TR, Rosen M, Bond J, Settles M, Roberts JS, Shields J, Jack L, Fox B (2002) Human therapeutic cocaine vaccine: safety and immunogenicity. Vaccine 20:1196\u20131204. https:\/\/doi.org\/10.1016\/s0264-410x(01)00425-x","journal-title":"Vaccine"},{"key":"5840_CR75","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.biopsych.2005.04.032","volume":"58","author":"BA Martell","year":"2005","unstructured":"Martell BA, Mitchell E, Poling J, Gonsai K, Kosten TR (2005) Vaccine pharmacotherapy for the treatment of cocaine dependence. Biol Psychiatry 58:158\u2013164. https:\/\/doi.org\/10.1016\/j.biopsych.2005.04.032","journal-title":"Biol Psychiatry"},{"key":"5840_CR76","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1002\/jat.3314","volume":"36","author":"P Baldrick","year":"2016","unstructured":"Baldrick P (2016) Dose site reactions and related findings after vaccine administration in safety studies. J Appl Toxicol 36:980\u2013990. https:\/\/doi.org\/10.1002\/jat.3314","journal-title":"J Appl Toxicol"},{"key":"5840_CR77","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.neuropharm.2017.01.031","volume":"122","author":"FT Crews","year":"2017","unstructured":"Crews FT, Lawrimore CJ, Walter TJ, Coleman LG (2017) The role of neuroimmune signaling in alcoholism. Neuropharmacology 122:56\u201373. https:\/\/doi.org\/10.1016\/j.neuropharm.2017.01.031","journal-title":"Neuropharmacology"},{"key":"5840_CR78","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/npp.2016.121","volume":"42","author":"MJ Lacagnina","year":"2017","unstructured":"Lacagnina MJ, Rivera PD, Bilbo SD (2017) Glial and neuroimmune mechanisms as critical modulators of drug use and abuse. Neuropsychopharmacology 42:156\u2013177. https:\/\/doi.org\/10.1038\/npp.2016.121","journal-title":"Neuropsychopharmacology"},{"key":"5840_CR79","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/164_2022_586","volume":"276","author":"J Liu","year":"2022","unstructured":"Liu J, Li JX, Wu R (2022) Toll-like receptor 4: a novel target to tackle drug addiction? Handb Exp Pharmacol 276:275\u2013290. https:\/\/doi.org\/10.1007\/164_2022_586","journal-title":"Handb Exp Pharmacol"},{"key":"5840_CR80","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1111\/adb.12261","volume":"21","author":"ZD Cooper","year":"2016","unstructured":"Cooper ZD, Johnson KW, Pavlicova M, Glass A, Vosburg SK, Sullivan MA, Manubay JM, Martinez DM, et al. (2016) The effects of ibudilast, a glial activation inhibitor, on opioid withdrawal symptoms in opioid-dependent volunteers. Addict Biol 21:895\u2013903. https:\/\/doi.org\/10.1111\/adb.12261","journal-title":"Addict Biol"},{"key":"5840_CR81","doi-asserted-by":"publisher","unstructured":"Dembic Z (2000\u20132013) The function of toll-like receptors. Toll and toll-like receptors: an immunologic perspective. Springer US, Boston, MA, pp 18\u201355. https:\/\/doi.org\/10.1007\/0-387-27445-6_2","DOI":"10.1007\/0-387-27445-6_2"},{"key":"5840_CR82","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1038\/mp.2014.177","volume":"20","author":"AL Northcutt","year":"2015","unstructured":"Northcutt AL, Hutchinson MR, Wang X, Baratta MV, Hiranita T, Cochran TA, Pomrenze MB, Galer EL, et al. (2015) DAT isn\u2019t all that: cocaine reward and reinforcement require toll-like receptor 4 signaling. Mol Psychiatry 20:1525\u20131537. https:\/\/doi.org\/10.1038\/mp.2014.177","journal-title":"Mol Psychiatry"},{"key":"5840_CR83","doi-asserted-by":"publisher","first-page":"9234","DOI":"10.3390\/cimb46080545","volume":"46","author":"SB Zaigham","year":"2024","unstructured":"Zaigham SB, Paeng DG (2024) Effects of Mucuna pruriens (L.) DC. and levodopa in improving Parkinson\u2019s disease in rotenone intoxicated mice. Curr Issues Mol Biol 46:9234\u20139244. https:\/\/doi.org\/10.3390\/cimb46080545","journal-title":"Curr Issues Mol Biol"},{"key":"5840_CR84","doi-asserted-by":"publisher","DOI":"10.1038\/srep11078","volume":"5","author":"H Pulikkalpura","year":"2015","unstructured":"Pulikkalpura H, Kurup R, Mathew PJ, Baby S (2015) Levodopa in Mucuna pruriens and its degradation. Sci Rep 5:11078. https:\/\/doi.org\/10.1038\/srep11078","journal-title":"Sci Rep"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-05840-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-026-05840-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-05840-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:17:55Z","timestamp":1774916275000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-026-05840-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":84,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5840"],"URL":"https:\/\/doi.org\/10.1007\/s12035-026-05840-w","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"5 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Our research did not involve human subjects.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Our research did not involve human subjects. Consent to participate is not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"538"}}